INS and hydrops fetalis: Concerning HF, this includes reduced cardiac inflammation, increased cardioprotective AMPK signaling, and increased myocardial glucose metabolism, the latter probably an indirect effect due to increased insulin secretion.151 To our knowledge, no studies specifically studied the impact of GLP-1R agonists on uremic cardiomyopathy and associated HF.